JCI "Fever Camera" Partners With China TVT
Johnson Controls (JCI) is the next big player to get into the 'fever camera' market. IPVM has confirmed the company is partnering with TVT who has also recently entered this market.
Inside this note, based on feedback from JCI, we examine:
- The TVT new offering
- How JCI is partnering with TVT
- How JCI is going to market
- JCI's intensions for UL and IEC 'certification'
- How this will impact the booming 'fever camera' market
TVT ********
*** ** * ******** ***** ***** surveillance *************** *** ~$** ******* ** **** revenue, ** ~*% **** **** ****. The ******* ********* **** ** ****** and **** *** ********* **** ***** its *** ***** ** ***** *******.
** *** **** *****, *** *** announced *** *** '***** *******' **** look *** *** ********* ******* ** other ***** ************ *******, ** ***** home **** ***** ***** *****:
***'* **-***** ******* ******* ****** ************ ******* ******** *** ****** ********** simultaneously ************ ** ********, ** *** excerpt ***** *****:
Partnering **** ***
**** ******** ***** ********* **** *** employees *** **** ******* ***, ******* that *** ******* ** ********* **** TVT, ** *** ******* ***** *****:
*** ********** ** **** **** ***** were ******** ********* *** ***** *** public ************. *******, ******* ** *** had **** **. *** ** ********* to ******** ******** **** ******** ** the **** *****.
NDAA ******** - *** ** ** ******
*** **** *********** **** **** **** making ************ ******** ** ***'* *** offering, ************ ** ***** ** **** approval *** ******** ** / *** 'certification'.
***** *** *** **** * ****-**** Dahua ***, *** *******, **** **** American ******* **********, *** **** ******* on *********** *** *** ** ****** products ** **********. *** *******'* ********* materials ********** **** ******* ***** ** NDDA ********, ** ***** *****:
*** ******* ********* **** *** **** Thermal ****** **** *** ********* ********* *****, ***** ** ****** *** *****-**** video ************ ******** *** ***** ***** are ******** ** *** **** ***.
****, *** *******'* ************* ***** ******** an **** ***** **** ****** '** ****** ** ********' *********** *** *** ******** ** **** (as ** ** *** ***** **** use). *** ********* ** ***** ** removed.
UL / *** '*************'
*** ******** ****** ** **** *** is ***************** *************, ** **** **** ******** overviewed:
*** ********* **** ***** ******* **:
***** ****** ** * ******* ****** under *** ********* ** *** *****-*-**:**** and *** ***/** ****:**** ***** **** be **** ** **** *********** *** medical ********* ********* *** *** *** 510 (*).
******* ********** ** **** ****:
********* ** *** ******* ********* *** explicitly ***** *** *** *****-*-* *** IEC *****-*-**:**** ** ** ******* **** that *** ******* **** ** ****** against.
** **** *** ***** ** *** video ************ ************ ******** **** ******** medical ** ***********. ** ** ******* to ** *** **** ** **** take *** ** ****** ****.
********, *** ******* ***** ** **** even ** *** ******* ** **** the ******* ** ******* ******* *********, *********** ** ********** ********** ** how ***** ****** *** *******. *** example, ** ** *** ***'* *********, the **** ****** ** **** ** screen ** ****** ************** (** **** just **** **** *), ** ***** fall *** ** *** ***********.
Benefits ** ***'* ****
********* *** ******* ********* **** ******** across *** *****, ******* **** *** or *** ***** ************ ************ *********. To *** ****** **** *** *** deliver ****, ** ***** ***** ********* obtaining **** ***, ** ***** ** importantly, **** *** ** * ******** boost ** ***** **** *******. ***, like **** *********, *** ***** ********** and******** *********** ****.
Downsides ** ***'* ****
*** ********* *** ******* ** ******* risks **** ***** ******* **** *** additional **** ** ******* **** *** with * ******* *****-***** ************. ***** JCI's ********* ** ******* **** *** standards *** *** **** *** *********, the ***** ** ***** ******* ***** misused ** ****** *********** *** ****.
Vote / ****
********** **** ***** ** **** * buck? **** ** ***, * ******* you'd ** ****** **** ****. ** you've ******* ******** ** *** **** 4 ****** ** ****** ** **'* time ** *** *** **** **** China *** *** ***. ***'* ****** these ********* *** *** ** **** still **** * ***?
*** *********** *** ******* ** **** using **** ******* ** ******* ***:
**, ** ******, **** ****** ***** on ********* ***, ** **** ****, they *** ****** ********* ******* *** material ******* ** *** ****, ***** we ** *** ******* ** *** or ****** ****.
** *** ***** ****, ********* ********* like *** ** *** **** (** often **** *****) ***** ******** ** market **** **** ****.
*** ***** **** *** ****** *** the ***** ** ****** * *** that **** ****** *****'* ***** ** their *******, *** ******* ** **** something **** ***** **** ** *********** from *** ********!